✦ LIBER ✦

Epidermal growth factor receptor tyrosine kinase inhibitors

✍ Scribed by Ranson, M

Book ID: 109998092
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 98 KB
Volume: 90
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6601873

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidermal growth factor receptor tyrosin

Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs): Simple drugs with a complex mechanism of action?

✍ Nicola Normanno; Monica R. Maiello; Antonella De Luca 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

## Abstract A range of target‐based agents for the treatment of solid tumors are in development. The epidermal growth factor receptor (EGFR) has been identified as a relevant target as it is involved in regulating several cellular functions important in the proliferation and survival of cancer cell

Mutations of the epidermal growth factor

Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer

✍ Tetsuya Mitsudomi; Yasushi Yatabe 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 987 KB

ChemInform Abstract: Syntheses of 4-(Ind

ChemInform Abstract: Syntheses of 4-(Indole-3-yl)quinazolines — A New Class of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.

✍ Anja Lueth; Werner Loewe 📂 Article 📅 2008 🏛 John Wiley and Sons ⚖ 39 KB 👁 2 views

Epidermal growth factor receptor tyrosin

Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer: results and open issues

✍ K. Bencardino; M. Manzoni; S. Delfanti; A. Riccardi; M. Danova; G. R. Corazza 📂 Article 📅 2007 🏛 Springer Milan 🌐 English ⚖ 117 KB

Epidermal growth factor receptor tyrosin

Epidermal growth factor receptor tyrosine kinase inhibitors in elderly or poor performance status patients with advanced non-small cell lung cancer

✍ Chia-Chi Lin; Chih-Hsin Yang 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 156 KB

Trying to compose the puzzle with all th

Trying to compose the puzzle with all the pieces: Epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer

✍ Massimo Di Maio; Cesare Gridelli; Nicola Normanno; Francesco Perrone; Fortunato 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

## Abstract Small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have shown promising activity in patients with non‐small cell lung cancer (NSCLC). Gefitinib has been the first of these drugs to be licensed for third‐line treatment of advanced NSCLC patients. Mor